SK hynix disclosed a new antitrust lawsuit in an amended Form F-1 filing with the SEC for its U.S. initial public offering. The California class-action suit alleges SK hynix and other chipmakers conspired to restrict supply and inflate DRAM prices starting in October 2022.
The company reaffirmed its plan to use IPO proceeds to expand manufacturing capacity despite the legal risk. SK hynix expects total expenditures for new South Korean facilities and advanced equipment to reach $7.6 billion through 2027.